Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin concentrations for pediatric lymphatic malformations
NCT06437158Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin in Lymphatic Malformation (LM), sponsored by West China Hospital of Sichuan University. Started Mar 2023; status: recruiting.
02
Drugs
bleomycin
03
Conditions
Lymphatic Malformation (LM)
Beyond the preview
Go deeper on NCT06437158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06437158.